Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Oct 05, 2018 6:55am
63 Views
Post# 28750169

RE:RE:RE:RE:Ph. 1b P#5's 9-month cystoscopy is Oct. 7 ...

RE:RE:RE:RE:Ph. 1b P#5's 9-month cystoscopy is Oct. 7 ...
skier59 wrote: You see Johnny BJ, fact of the matter is, if it works in Canadian Humans, chances are almost 100% it will also work in the American Humans, and for that matter all humans around the world. We don't really need you, as you imply. As a matter in fact you will need us, that is if you are interested in having a real viable treatment/cure for possibly many forms of cancer ! Personally with your current government in power, us Canadians don't really have the trust we once had in our Southern Neighbors. It's a big world out there and I'm sure many other countries will want to buy our treatment/cure having only the HC certification. Do you really think Europe and Asia care about FDA providing we have a HC certification?  Besides, aren't there strange things going on with the FDA, you know, nudge nudge, wink wink, $$$$$$$....Big Pharma.


Out of the mouth of babes.

It is imperative that management assures the market by what means they will raise the capital to pay for the NMIBC trial and I might add without the smoke & mirrors of the last PP. As it stands right now there will be no phase 2 trial due to the lack of funds. That $1.1 million from the PP will be used to mostly cover everyday corporate expenses and past research commitments until the end of the year. If anyone begs to differ then save us the fantasy theories and show investors real money not imagined currency. BTW, it is no act of confidence in the science when insiders contributed over $300,000 to the PP. They essentially received the shares and warrants for free since it allows them to collect a company pay cheque for another 4 months.

Let's not deviate from the from the question that overrides everything else. This is where management has to show their mettle and inform shareholders what steps they are taking to guarantee that funding the phase 2 trial will not be an issue. Many on this board have praised management in the past. Let's hope you trust wasn't misplaced.
Bullboard Posts